OPKO Health, Inc.
OPKHealthcareNASDAQDiagnostics & Research · Last scanned Sep 8, 2026
Scan Results
Daily timeframeOPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. With a market capitalization of $1.22B, it sits in small-cap territory. The company operates in two segments, Pharmaceutical and Diagnostics.
Market Cap
$1.22B
Beta
1.50
P/E (TTM)
—
P/E (Fwd)
-5.96
EPS (TTM)
$-0.07
EPS (Fwd)
$-0.28
ROE
-5.9%
ROA
-5.5%
Cash
$300.8M
Total Debt
$398.1M
Free CF
$54.8M
52W Change
16.3%
Annual Financials
Cash vs Debt
Where OPK stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, OPK finished 32.03% above its 150-day moving average ($1.28) and 31.01% above its 200-day moving average ($1.29). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is OPK overbought or oversold?
At the September 3, 2026 close, OPK's RSI(14) was 82.2, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $300.8M in cash, though total debt stands at $398.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $54.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -5.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $1.00B (2022) to $606.9M (2025), a 40% decline worth watching.
OPKO Health, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence OPKO Health, Inc.'s trajectory.